Lower riskMedical device recall · FDA · Published August 13, 2021
Greiner Bio-One VACUETTE 6ml Blood Tubes Risk of Clotting
Greiner Bio-One recalls 6ml K2EDTA blood collection tubes with pink caps that may clot during use. Affected lots expire 09/2022 or 11/2022. Stop using immediately to avoid inaccurate blood tests.
Blood collection tubes may experience a clotting issue.
Take action
Contact the company
📍Recalling firmGreiner Bio-One North America, Inc.4238 Capital Dr · Monroe, NC 28110-7681
✎ GovInfoNow plain-language explainer
Greiner Bio-One is recalling 6ml blood collection tubes that may clot during use. This could lead to inaccurate blood test results if the tubes are used without proper anticoagulant. Affected tubes have specific lot numbers and expiration dates. Read more at govinfonow.com/recall/61950-greiner-bio-one-vacuette-6ml-blood-tubes-risk-of-clotting.
“Greiner Bio-One VACUETTE 6ml Blood Tubes Risk of Clotting.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/61950-greiner-bio-one-vacuette-6ml-blood-tubes-risk-of-clotting. Based on FDA recall #Z-2485-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2485-2021%22&limit=1).
Greiner Bio-One North America, Inc. voluntarily recalled VACUETTE blood collection tubes on Aug. 13, 2021, after they may experience clotting issues, according to the FDA. Owners should contact the company for a refund.
Lot Codes: B21033DA (exp. 09/08/2022), B21053R8 (exp. 11/10/2022)
UDI Case: 39120017571248
UDI Rack: 29120017571241
Distribution: AL, AZ, CO, CT, FL, IL, MA, MD, MI, MO, NC, NM, PA, TX, VA, and Canada
The hazard
The blood collection tubes may experience a clotting issue, according to the FDA.
Context
GovInfoNow's records show Greiner Bio-One North America, Inc. has 11 other recalls on record since 2019-11-25. Other recent recalls of similar products include Vacuette 8ml CAT Serum Separator Clot Activator Tubes May Cause Incorrect Test Results (2025-08-19) and Greiner Bio-One VACUETTE Tube Recall: Clotting Issues May Delay Treatment (2024-05-14).
How to tell if you have this one
Check for the pink cap with a pink ring and non-ridged design. Affected lots are B21033DA (exp. 09/2022) or B21053R8 (exp. 11/2022).
Brand
Greiner Bio-One
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Stop Using Immediately
Discard the affected tubes to prevent inaccurate blood test results.
Where it went and when
Where it was distributed
Distributed in 15 states, and outside the U.S.
Listed by the agency
Not listed
FDA distribution: “Distribution was made to AL, AZ, CO, CT, FL, IL, MA, MD, MI, MO, NC, NM, PA, TX, and VA. Foreign distribution was made to Canada.” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Alabama, Arizona, Colorado, Connecticut, Florida, Illinois, Maryland, Massachusetts, Michigan, Missouri, New Mexico, North Carolina, Pennsylvania, Texas, Virginia.
Recall timeline
FDA terminated this recall 2 years after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-2485-2021 (August 13, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2485-2021 to see it in context.
Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.